At a glance
ClinicalIndex Comparison RecordN/ACompleted· 10 enrolled / 10 target
Drug / intervention
CI632 Slim Modiolar Electrodedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pre-market, Open-label Feasibility, Prospective, Single-arm Multicenter Feasibility Investigation of Hearing Performance Using the CI632 in Adults With Low-frequency Residual Hearing.
In Brief
A clinical study evaluating CI632 Slim Modiolar Electrode for Sensorineural Hearing Loss and Low-Frequency Residual Hearing. Completed, enrolled 10 participants across 4 sites.
Signals
Enrollment appears stalled
Detailed Summary
The purpose of the feasibility study is to investigate hearing performance (audiometry and speech perception) using the CI632 in a group of adults (n=15) with low-frequency residual hearing who meet inclusion criteria.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202120222023202420252026
First PostedFeb 2021
Enrollment StartDec 2021
Primary CompletionJun 2025
TodayJul 2026
First PostedFeb 5, 2021
Enrollment StartDec 16, 2021
Primary CompletionJun 16, 2025
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 5.4 years ago
Arms & Interventions
CI632 Slim Modiolar Electrodeexperimental
Device: CI632 Slim Modiolar Electrode
Interventions
CI632 Slim Modiolar Electrodedevice
Cochlear Ltd CI632 cochlear implant with Slim Modiolar Electrode